TK001

· Jiangsu T-Mab Biopharma Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TK001, covering 2018-03-01 to 2018-03-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular Degeneration [Phase 1]

See pricing